Smriti Bansal | Nanomedicine | Best Researcher Award

Published on by Top Pharmaceutical

Smriti Bansal | Nanomedicine | Best Researcher Award

Ms Smriti Bansal, Netaji Subhas University of Technology, India

Ms. Smriti Bansal is a Ph.D. candidate in Chemistry, specializing in nanoparticle fabrication, water remediation, drug delivery, and antimicrobial studies. Her research focuses on creating transition metal-based nanoparticles for catalytic studies, contributing to both environmental sustainability and medicinal chemistry. She has authored high-impact publications in journals like ACS Applied Biomaterials and Ceramics International, and presented her work at international conferences. A research fellow at Netaji Subhas University of Technology, she is also a reviewer for top journals. Her leadership, interdisciplinary contributions, and recognition make her a deserving candidate for the Best Researcher Award.

Publication Profile

google scholar

Academic Qualification

Ms. Smriti Bansal is a dedicated academician with a strong background in chemistry. She completed her Ph.D. in Chemistry from Netaji Subhas University of Technology, Dwarka, New Delhi, in 2019 (thesis submitted). She earned her M.Sc. in Organic Chemistry from PDMU, Department of Chemistry, with an impressive 87.2% in 2018. Her B.Sc. in Analytical Chemistry from the University of Delhi (2015) further solidified her expertise, with a notable 78% score. Smriti’s academic journey began at Triveni Memorial Sr. Sec. School, where she excelled in both her H.S.C. (82.8%) and S.S.C. (83.6%) exams. 🎓🔬📚

Teaching Experience

Smriti Bansal is a dedicated academic professional with a strong background in chemistry. She currently serves as a Teaching Research Fellow at the Department of Chemistry, Netaji Subhas University of Technology, Dwarka, New Delhi, where she has been contributing to the field of Engineering Chemistry and Organic Chemistry since December 19, 2019. 📚🔬 Previously, she held the position of Assistant Professor at the Department of Applied Sciences, Delhi Technical Campus, Maharshi Dayanand University, where she taught Engineering Chemistry for one year. Her passion for research and teaching continues to inspire students and elevate the academic community. 👩‍🏫📖

Achievements

Ms. Smriti Bansal has made significant contributions to the field of nanotechnology and research. She successfully completed the “Nanotechnology: A Maker’s Course” online program, offered by Duke University, North Carolina State University, and the University of North Carolina at Chapel Hill through Coursera 🎓. She also serves as a reviewer for prestigious journals such as the International Journal of Biological Macromolecules by Elsevier and the Indian Journal of Physics by Springer 📚. Her research on “Fabrication and Photocatalytic evaluation of functionalized chitosan decorated vanadium pentoxide nano-adsorbents for water remediation” earned her the Commendable Research Award 🏆. Additionally, she is a life member of the Society of Young Biomedical Scientists (SYBS), India 🔬.

Conferences Attended

Ms. Smriti Bansal has actively participated in various prominent workshops and conferences to enhance her expertise. She attended the 7th Workshop on Computational Chemistry of Materials (CCM-2022) organized by the Centre for Advanced Computational Chemistry Studies, Delhi 🧑‍🔬. She also took part in the 5-day residential training program on Pre-Clinical Development of Medicinal and Aromatic Plant-Based Leads at CSIR-CIMAP, Lucknow 🌿. Ms. Bansal participated in the Organic Chemistry Series (OCS-2024) on catalysis for green synthesis 🌱, and the Fostering Sustainable Catalysis – 2024 event 🔬. Furthermore, she joined the National Conference on Environmental Sustainability in Wastewater Remediation (ESWR-2017) and on e-learning MOOCs & Quality in Higher Education 📚.

work Presented

Ms. Smriti Bansal has actively presented her research at numerous prestigious conferences. She delivered an oral talk on “Functionalized Chitosan-Coated Vanadium Pentoxide Nanoparticles” at the Fifth Science Conclave and NBRCOM 2024, organized by AIIMS and SCMM, JNU 🧑‍🔬. Additionally, she presented her work on “DECORATED VANADIUM PENTOXIDE NANODRUGS” at the International Symposium on Advanced Materials (CTAM-2024) 🎤. She also shared her research at AMSET-2023 in Malaysia on photocatalytic evaluation 🌏, and at ICONPAC-2022 on nano-photocatalysts 🌱. Ms. Bansal has contributed to multiple other conferences, including ICRACS-2022, and presented posters and papers on diabetes treatment and water remediation 🌊.

Research Focus

Smriti Bansal’s research focuses on the development of advanced nanomaterials for environmental and biomedical applications. She investigates the fabrication of functionalized nanomaterials, such as chitosan-decorated vanadium pentoxide nanoparticles, for water remediation, photocatalysis, and drug delivery systems. Her work also explores green synthesis approaches for vanadium nanoparticles, emphasizing sustainability and environmental protection. Bansal’s interdisciplinary studies extend into antibacterial, antioxidant, and cytotoxic activities, alongside in silico molecular docking for drug design. Her research has significant implications in environmental sustainability, nanotechnology, and healthcare. 🌍🔬💊

Publication Top Notes

Fabrication and photocatalytic evaluation of functionalized chitosan decorated vanadium pentoxide nano-adsorbents for water remediation

A review on green approaches utilizing phytochemicals in the synthesis of vanadium nano particles and their applications

Direct synthesis of Poly (Ԑ-Caprolactone)-block-poly (glycidyl methacrylate) copolymer and its usage as a potential nano micelles carrier for hydrophobic drugs

In vitro Antibacterial Evaluation and in silico Docking of Schiff Base as a Potential Inhibitor of Nucleoside Diphosphate Kinases
Green Nanocomposites: Incorporating Biopolymers into Plastics for Enhanced Environmental Sustainability
Vanadium Pentoxide-Based Nanomaterials for the Treatment of Dye-Containing Wastewater to Avoid Negative Effects on the Environment and Human Health

Roxana Matran | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Roxana Matran | Pharmacology | Best Researcher Award

Assist Prof Dr Roxana Matran, UMF “Carol Davila”, Romania

Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic with a Ph.D. from Carol Davila University of Medicine and Pharmacy (2017) 🎓. An Assistant Professor at the same university since 2019, she excels in teaching and research on pediatric pulmonology and gastroenterology. Her clinical expertise at “Grigore Alexandrescu” Emergency Hospital for Children includes contributions to groundbreaking clinical trials on inflammatory bowel diseases 🏥🔬. A dedicated volunteer with MD Caravana cu Medici 🤝, she brings healthcare to underserved communities. Dr. Matran’s active membership in ESPGHAN and advisory roles showcase her impactful influence in public health policy 🌍✨.

Publication Profile

orcid

Educational Backgrounds

Assist. Prof. Dr. Roxana Matran embarked on her academic journey at the prestigious Central School in Bucharest, where she specialized in Mathematics-Informatics with bilingual French instruction (📘✏️). She continued her education at “Carol Davila” University of Medicine and Pharmacy, earning a Bachelor’s Degree in 2009 (🎓🩺). Driven by her passion for medicine, she pursued a Ph.D. at the same university, completing her thesis on factors contributing to pulmonary disease in cystic fibrosis between 2013 and 2017 (📄🫁). Her dedication and expertise in the medical field have solidified her reputation as a leading academic and researcher in Bucharest (🌟🏥).

Work Experiance

Assist. Prof. Dr. Roxana Matran is a distinguished pediatric gastroenterologist and academic based in Bucharest. She serves as a member of the Advisory Committee on Post-Vaccination Adverse Reactions, analyzing vaccine-related health concerns (💉📊). She is also a sub-investigator in pivotal clinical trials, including studies on Vedolizumab and Adalimumab for pediatric Crohn’s disease and ulcerative colitis (🔬📑). Dr. Matran volunteers with Caravana cu Medici, offering medical consultations in underserved Romanian villages (🚑🤝). As an Assistant Professor at “Carol Davila” University, she teaches fifth-year medical students and conducts extensive research (📚👩‍🔬). Her work at “Grigore Alexandrescu” Emergency Hospital focuses on consultations, rounds, and clinical studies (🏥👶).

Membership

Assist. Prof. Dr. Roxana Matran is an active member of esteemed professional organizations in her field. Since June 2019, she has been a Full Member of the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN), contributing to advancements in pediatric healthcare across Europe (🌍👶🩺). Additionally, she has been a dedicated member of the Romanian Society of Pediatrics since July 2016, working to promote excellence in pediatric medicine and research in her home country (🇷🇴📚💉). Her involvement in these societies underscores her commitment to improving children’s health and staying at the forefront of medical advancements (🌟🔬).

Conference and Seminars

Assist. Prof. Dr. Roxana Matran has an extensive track record of participation in prestigious medical events and specialized training programs worldwide. In 2024, she is set to attend the 5th Liver Transplant School in Brussels (25–28 September) and the ESPGHAN Mastercourse in Parenteral Nutrition in Linz, Austria (4–6 March). Her prior engagements include the ESPGHAN IBD Masterclass in Helsinki, Finland (2022) and the International Symposium on Pediatric Inflammatory Bowel Disease in Edinburgh, Scotland (2022). Over the years, she has honed her expertise in pediatric gastroenterology, nutrition, and pulmonology, attending courses in Italy 🇮🇹, Austria 🇦🇹, France 🇫🇷, and Greece 🇬🇷, and even completing a post-graduate program online 🌐.

Community Impact

Assist. Prof. Dr. Roxana Matran is deeply committed to serving underserved communities, demonstrating her passion for equitable healthcare access. She actively volunteers with MD Caravana cu Medici, a noble initiative providing essential medical consultations in impoverished Romanian villages 🏡. Through this work, Dr. Matran brings her expertise in pediatric gastroenterology and nutrition to those who need it most, offering care, guidance, and hope 🌟. Her dedication to improving public health goes beyond the clinic, reflecting a strong sense of compassion and responsibility toward marginalized populations 🤝. Dr. Matran’s efforts exemplify the true spirit of community service and medical care ❤️.

Clinical Expertise

Assist. Prof. Dr. Roxana Matran has made significant contributions to pediatric gastroenterology through her clinical practice, research, and involvement in clinical trials. As a pediatric gastroenterologist at “Grigore Alexandrescu” Emergency Hospital for Children 🏥, she seamlessly combines patient care with groundbreaking research. Dr. Matran has actively contributed as a subinvestigator for leading pharmaceutical companies, including Takeda Pharmaceuticals (VedolizumabSC-3003) and AbbVie (Adalimumab), advancing therapies for pediatric inflammatory bowel disease 🔬. She also researches post-vaccination adverse reactions as a member of the Advisory Committee at the Ministry of Health, ensuring better health outcomes for children globally 💉.

Research Focus

Dr. Roxana Elena Smădeanu’s research focus primarily revolves around pediatric health, with a special emphasis on diagnosing and managing complex diseases such as cystic fibrosis, intestinal tuberculosis, and respiratory conditions in children. Her work includes exploring microbiota’s role in functional abdominal pain disorders, respiratory symptomatology associated with COVID-19 in pediatric patients, and rare genetic syndromes like Menke-Hennekam syndrome. Additionally, her research delves into diagnostic methods like sweat conductivity in cystic fibrosis. This body of work aligns with clinical and laboratory research aimed at improving pediatric healthcare and diagnostics. 🧑‍🔬🩺👶

Publication Top Notes

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center

Food Related Quality of Life in Children with Chronic Gastrointestinal Disorders: Comparative Study Between Inflammatory Bowel Disease and Celiac Disease—Reports from a Romanian Center

Anti TNF-a Use in Pediatric Inflammatory Bowel Disease – Reports from a Romanian Center

Quality of Life of Pediatric Patients with Chronic Intestinal, Liver, and Pancreatic Diseases During the COVID-19 Pandemic

Menke–Hennekam Syndrome: A Literature Review and a New Case Report

Qingfeng Chen | Bioinformatics in Pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Qingfeng Chen | Bioinformatics in Pharmaceuticals | Best Researcher Award

Prof Qingfeng Chen, Guangxi University, China

Prof. Qingfeng Chen is a distinguished leader in bioinformatics, data mining, and artificial intelligence. With a Ph.D. in Computer Science from the University of Technology Sydney, he has made significant contributions to drug-target interaction prediction, RNA structure identification, and protein kinase regulation. An active academic leader, he serves as the Chairman of the Guangxi Bioinformatics Association and has held editorial roles in top journals. His extensive publication record and leadership in international conferences reflect his influence. Prof. Chen’s mentorship and dedication to advancing interdisciplinary research make him a trailblazer in his field. 📚💻🔬🌍

Publication Profile

scopus

Educational Backgrounds

Professor Qingfeng Chen holds a Doctor of Philosophy in Computer Science and Technology from the University of Technology Sydney (2004) 🎓. He earned a Master of Mathematics from Guangxi Normal University in 1998, following his Bachelor’s degree in Mathematics from the same institution in 1995 📚. His academic journey reflects a strong foundation in both mathematics and computer science, positioning him as an expert in these fields. With a distinguished academic background, Prof. Chen continues to contribute significantly to the advancement of technology and mathematical research 🔍.

Editorial Role

Prof. Qingfeng Chen is a highly regarded academic, serving as an Associated Editor for Complexity & Intelligent Systems and the Journal of Bioinformatics. He has also contributed as a Guest Editor for notable journals such as Current Protein & Peptide Science, Engineering Letters, and IAENG (International Association of Engineers). Additionally, Prof. Chen serves as a Journal Reviewer for esteemed publications, including Data Mining and Knowledge Discovery, IEEE Transactions on Knowledge and Data Engineering, IEEE Transactions on Information Technology in Biomedicine, Briefing in Bioinformatics, Information Science, Knowledge and Information Systems, and IEEE Transactions on Evolutionary Computation 📚💻🔬.

Current Position

Prof. Qingfeng Chen has held several prestigious positions throughout his career. Since July 2009, he has been a Professor of Bioinformatics, Data Mining, and Artificial Intelligence at the Department of Computer and Electronic Information, Guangxi University. He has also served as an Honorary Research Fellow at La Trobe University in Australia since May 2016. In addition, he is the Chairman of the Guangxi Bioinformatics Association (since August 2022) and the Executive Deputy Director of the Biomedical Informatics Committee of the Guangxi Artificial Intelligence Society (since August 2020). Previously, he was an Honorary Visiting Professor at the University of Technology Sydney and a Research Fellow at City University of Hong Kong 🔬🎓🌍.

Conference Leadership

Prof. Qingfeng Chen has made significant contributions to the academic community, not only through his impactful research and publications but also by showcasing his leadership in organizing key conferences. He has chaired prominent events such as the 12th International Conference on Bioinformatics and Biomedical Science (ICBBS 2023), where his expertise guided discussions on bioinformatics and biomedical advancements. Additionally, he has co-chaired several other international conferences, highlighting his dedication to advancing bioinformatics and artificial intelligence. Through these efforts, Prof. Chen continues to shape and influence the future of these rapidly evolving fields 📅💡🌍.

Extensive Research

Prof. Qingfeng Chen has published a vast array of influential papers and monographs, establishing himself as a leader in bioinformatics. His groundbreaking work in drug-target interaction prediction, RNA structure identification, and protein kinase regulation is highly respected. Notable books such as Intelligent Strategies for Pathway Mining and Secure Transaction Protocol Analysis highlight his expertise in computational biology. Prof. Chen’s journal papers, covering topics like circRNA-disease association prediction and the evolution of SARS-CoV-2, are widely cited and published in prestigious journals like IEEE Transactions on Knowledge and Data Engineering and IEEE Transactions on Computational Biology and Bioinformatics 📖🔬💡.

Research Focus

Professor Qingfeng Chen’s research primarily focuses on advanced computational biology, particularly in the integration and analysis of multi-omics data for precision medicine. His work involves developing machine learning frameworks, such as interpretable multitask learning models and graph convolutional networks, for predicting cancer outcomes, understanding immune responses, and improving drug-target interaction predictions. His research also explores the application of deep learning techniques to predict responses to therapies like immune checkpoint inhibitors. With a keen interest in cancer biology, his studies aim to enhance biomarker discovery and optimize therapeutic strategies. 🔬💡

Publication Top Notes

scMoMtF: An interpretable multitask learning framework for single-cell multi-omics data analysis

Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular carcinoma

A semi-supervised approach for the integration of multi-omics data based on transformer multi-head self-attention mechanism and graph convolutional networks

Noise-Resilient Unsupervised Graph Representation Learning via Multi-Hop Feature Quality Estimation

Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma

Bi-SGTAR: A simple yet efficient model for circRNA-disease association prediction based on known association pair only

DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery

IBPGNET: lung adenocarcinoma recurrence prediction based on neural network interpretability

Entity Alignment Based on Dynamic Graph Attention and Label Propagation

NGCN: Drug-target interaction prediction by integrating information and feature learning from heterogeneous network

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Mr Victor Ajayi, University of Medical sciences Ondo Nigeria, Nigeria

Mr. Oluwadamilola Victor Ajayi is a distinguished academic and researcher in human physiology 🧬, with a B.Tech, M.Sc., and M.Phil. from reputable institutions. His groundbreaking research focuses on anti-ulcerogenic and antioxidant effects, phytochemical profiling, and bioactive compounds’ therapeutic roles 🩺. With over a decade of teaching experience at UNIMED 🎓, he excels in curriculum development and research mentorship. A member of esteemed bodies like PSN and Physoc 🏅, Mr. Ajayi actively engages in advancing physiology through publications and conferences. His dedication to science and education makes him a standout contributor in his field 🌍.

Publication Profile

orcid

Educational Backgrounds

Victor Ajayi’s academic journey spans several prestigious institutions. He is currently pursuing an M.Phil in Human Physiology at the Federal University of Technology, Akure (FUTA), starting in November 2024. He previously attended the University of Medical Sciences (UNIMED), Ondo, from August 2022 to December 2024, and earned his M.Sc. in Human Physiology from the University of Ibadan in November 2018. Victor completed his B.Tech in Human Physiology at Ladoke Akintola University of Technology (LAUTECH) in November 2011. His earlier academic milestones include WAEC (2009) and NECO (2002). 🎓📚👨‍🎓

Work Experience

Victor Ajayi has a diverse work experience spanning various roles in academia and healthcare. He started with industrial training as a Technologist at Spring Specialist Hospital in 2010, followed by NYSC at Ondo State School of Nursing, where he taught Physiology and Anatomy. Victor later worked as a teacher and guest tutor at different institutions, including Integrity Nursery, Ondo State School of Nursing, and several colleges. At the University of Medical Sciences, he serves as an Assistant Lecturer, course coordinator, and level adviser, while also supervising graduate students. His contributions to Physiology education remain invaluable. 🏥📚👨‍🏫

Membership

Mr. Victor Ajayi D. is an active member of esteemed professional bodies such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc). Over the years, he has attended several notable conferences and workshops, including the 28th and 29th Scientific Conferences of PSN at the University of Ilorin in 2008 and 2009, and the 31st conference at Lagos State University in 2011. He also participated in workshops on pedagogy, effective communication, animal ethics, and integrated registration. His dedication to continued learning is evident in his certified seminar attendance, such as the Bioinformatics and Genomics course in October 2024. 📚🔬🧑‍🏫

Community and Professional Engagement

Mr. Victor Ajayi has consistently showcased remarkable leadership in professional communities. As a dedicated member of esteemed organizations such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc), he has made significant contributions to the advancement of his field. His active participation in numerous conferences and workshops underscores his commitment to continuous learning and staying at the forefront of his profession. Through these engagements, Mr. Ajayi has demonstrated a passion for professional growth and a commitment to fostering collaboration within the scientific community. His involvement continues to inspire and influence others in the field. 💼📚

Accolades and Recognition

Mr. Victor Ajayi has made significant contributions to research, education, and professional development, positioning him as a strong contender for the Best Researcher Award. Although his CV does not highlight specific prior awards, his innovative approaches to addressing physiological challenges and his commitment to advancing scientific knowledge demonstrate his potential. Additionally, his dedication to mentoring the next generation of researchers reflects his passion for nurturing talent and fostering academic growth. Mr. Ajayi’s work continues to inspire and impact the research community, showcasing his outstanding ability to drive change and innovation in his field. 🏆📚🔬

Research Focus

Mr. Victor Ajayi’s research focuses on the anti-inflammatory and anti-oxidative effects of pasteurized yoghurt in mitigating gastric ulceration induced by indomethacin in male Wistar rats. This study delves into gastrointestinal health and the potential therapeutic benefits of food-based interventions in inflammatory conditions. His work contributes to pharmacology, nutritional science, and biomedical research with an emphasis on how diet and natural substances can influence disease progression and provide alternative treatments. This aligns with the field of Pharmacological Toxicology and Gastroenterology, exploring the intersection of nutrition and pharmacology in disease management. 🧑‍⚕️🍽️💊

Publication Top Notes

Anti-inflammatory and anti-oxidative effect of pasterurised yoghurt in indomethacin induced gastric ulceration in male Wistar rats

Ratree Sawangjit | Pharmacovigilance | Best Researcher Award

Published on by Top Pharmaceutical

Ratree Sawangjit | Pharmacovigilance | Best Researcher Award

Assist Prof Dr Ratree Sawangjit, Mahasarakham University, Thailand

Assist. Prof. Dr. Ratree Sawangjit 🌿, a distinguished educator and researcher, has been a faculty member at Mahasarakham University’s Faculty of Pharmacy since 2006. She earned her Ph.D. in Biopharmaceutical Sciences 🧪 from Mahidol University. Her expertise spans clinical trials, herbal medicine, and evidence-based synthesis 📊. As Head of CTEBs Research Unit and IRB/EC, she leads impactful research projects. Dr. Sawangjit has held roles at Monash University 🌏 and contributed to WHO-GCTM initiatives. Recognized as an outstanding researcher 🏆, her work bridges clinical pharmacology, public health, and education, fostering innovative healthcare solutions.

Publication Profile

Google Scholar

Education

Assist. Prof. Dr. Ratree Sawangjit is a distinguished academic in pharmaceutical sciences 🎓💊. She earned her Ph.D. in Biopharmaceutical Sciences (International Program) from Mahidol University, Faculty of Pharmacy, Bangkok, Thailand (2008-2012) 🧪📚. Prior to this, she completed her Master’s in Pharmacy, specializing in Pharmaceutical Sciences (International Program), at Naresuan University, Thailand (2004-2006) 🏫🔬. Her journey in pharmacy began with a Bachelor of Pharmacy degree from Chiang Mai University, Thailand (1999-2004) 🌿📖. With her extensive education and expertise, she contributes significantly to the field of biopharmaceutical sciences through teaching and research 🌟📊.

Experience

Assist. Prof. Dr. Ratree Sawangjit is a dedicated faculty member at the Department of Clinical Pharmacy, Mahasarakham University (2006–present) 📚💊. She earned her Ph.D. in Biopharmaceutical Sciences from Mahidol University 🎓 (2012) and holds advanced degrees in Pharmacy from Naresuan and Chiang Mai Universities. Dr. Sawangjit mentors students in clinical pharmacology, integrating research and practice 🧪✨. As a Clinical Research Associate (2009–2020), she contributed to impactful public health policies 🌍💡. She also led health promotion projects and served as Assistant Dean for Student Affairs (2013–2015) 🎓🤝. Currently, she heads the IRB/EC, ensuring ethical compliance in research standards ✅📋.

Research Expertise

Assist. Prof. Dr. Ratree Sawangjit is an expert in clinical trials, specializing in the design, implementation, and analysis of studies with a focus on herbal and alternative medicines 🌿🧪. She excels in evidence-based synthesis, conducting systematic reviews, meta-analyses, and network meta-analyses 📚📊. Her expertise extends to clinical pharmacology, particularly in pain and inflammation management 💊🔥. Additionally, she is proficient in health economic evaluation, including cost-effectiveness analysis and healthcare resource utilization analysis 💰🏥. Dr. Sawangjit’s work combines cutting-edge research with practical applications, advancing both patient care and healthcare efficiency. 🌟

Awards and Honors

Assist. Prof. Dr. Ratree Sawangjit is an accomplished academic and researcher. She earned a Bachelor of Pharmacy with second-class honors from Chiang Mai University in 2004 🎓💊. Supported by the Thailand Research Fund, she completed her Master’s (2004–2006) and Ph.D. (2008–2012) programs 🧠📚. As a visiting research assistance scholar, she collaborated with Monash University’s School of Pharmacy in Malaysia (2015–2016) 🌏🔬. She was named Outstanding Researcher of the Faculty of Pharmacy at Mahasarakham University in 2019 and Outstanding Researcher of Mahasarakham University in 2021 🏆✨. Her journey reflects dedication to advancing pharmaceutical education and research. 🌟

Research Focus

Assist. Prof. Dr. Ratree Sawangjit’s research focuses on evidence-based healthcare, particularly through systematic reviews and meta-analyses. Her studies span diverse areas, including burn wound healing 🌱🔥, pharmacological treatments for dementia-related agitation 🧠💊, peripheral neuropathy 🌐🦶, and nonalcoholic fatty liver disease 🩺🫀. She has also investigated the cost-effectiveness of genetic testing in preventing drug-induced reactions 🧬💉 and assessed cannabis and cannabinoids for pain management 🌿🤕. Other key areas include treatments for eczema 🧴🛁 and musculoskeletal pain 🦴🩹. Dr. Sawangjit’s work significantly contributes to optimizing therapeutic interventions and advancing global health outcomes. 🌍📚

Publication Top Notes

The efficacy of aloe vera used for burn wound healing: a systematic review

Cost-effectiveness analysis of HLA-B* 5801 testing in preventing allopurinol-induced SJS/TEN in Thai population

Effectiveness of pharmacy‐based needle/syringe exchange programme for people who inject drugs: a systematic review and meta‐analysis

Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis

Efficacy and safety of mecobalamin on peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis

The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis

 

 

 

Dvora Joseph Davey | Clinical Trials | Best Researcher Award

Published on by Top Pharmaceutical

Dvora Joseph Davey | Clinical Trials | Best Researcher Award 

Dr Dvora Joseph Davey, University of California, Los Angeles, UCLA, South Africa

Dr. Dvora Joseph Davey is a distinguished epidemiologist with a focus on infectious diseases, particularly HIV and STIs. Holding a Ph.D. in Epidemiology from UCLA, her research, mainly in sub-Saharan Africa, aims to reduce the burden of HIV through innovative interventions. As a Principal Investigator in clinical trials, Dr. Davey has contributed significantly to global HIV prevention efforts, especially for pregnant women. She is actively involved in policy-making with groups like the WHO and NIH, shaping global health initiatives. Her leadership, extensive research, and mentorship in global health make her an exemplary figure in public health. 🌍🔬💉

Publication Profile

google scholar

scopus

orcid

Education

Dr. Dvora Joseph Davey has an impressive academic background, beginning with a B.A. in International Affairs and French from the University of Colorado, Boulder, in 1998. She went on to earn a Master of Public Health (M.P.H.) in Population and Reproductive Health Sciences from Columbia University in 2003. Dr. Davey completed her Ph.D. in Epidemiology at the University of California, Los Angeles, in 2016, followed by a fellowship in Epidemiology of HIV at the University of North Carolina in 2017. She furthered her expertise with a postdoctoral fellowship in Global HIV Prevention at UCLA in 2018. 🌍📚

Scientific Appointments

Dr. Dvora Joseph Davey has held several prestigious positions throughout her career. Currently, she serves as an Associate Professor in Infectious Diseases and Epidemiology at UCLA’s School of Medicine and School of Public Health, respectively. She also holds honorary roles at the University of Cape Town and Desmond Tutu Health Foundation. Dr. Davey’s research includes being the Principal Investigator on a study about sexual behavior and PrEP acceptability. Her past positions include HIV Director at Population Services International in Mozambique and Director at the Rwanda-Emory HIV Research Group. With her diverse roles, Dr. Davey has had a significant global impact. 🌍🩺📊

Professional Memberships

Dr. Dvora Joseph Davey has made significant contributions to the field of HIV and reproductive health, serving as an Assistant Editor for renowned journals such as AIDS, JIAS, and PloS Global Health. She is also an active member of the South African Clinical Research Association and the American Public Health Association. Her honors include invitations to present at major conferences like HIVR4P 2024 in Peru and WHO Working Group meetings. Dr. Davey has co-chaired several influential research working groups, including on PrEP in pregnancy, and received multiple awards, including UCLA’s Epidemiology Department Summer Fellowship. 🌍📚🎤

Awards

Dr. Dvora Joseph Davey is a renowned researcher whose work focuses on HIV prevention and treatment, particularly in pregnant and breastfeeding women. Her studies address key challenges in high HIV incidence communities, especially in Sub-Saharan Africa. Dr. Davey investigates Pre-exposure Prophylaxis (PrEP) access, adherence, and effectiveness among pregnant women, emphasizing the need for female-controlled HIV prevention methods during vulnerable periods. Additionally, she explores the integration of STI testing, alcohol use, and the impact of intimate partner violence on HIV risk. Her contributions significantly influence HIV-related healthcare policies, aiming to reduce transmission and improve outcomes in these populations. 👩‍🔬🌍💉

Policy Involvement

Dr. Dvora Joseph Davey has made significant contributions to national and international HIV and STI policy-making. Her leadership in key working groups, including the National PrEP and Prevention of Vertical Transmission of HIV Working Groups, as well as the World Health Organization’s Working Group on Long-Acting PrEP in pregnancy, highlights her expertise and influence. These positions enable Dr. Davey to play a pivotal role in translating scientific research into actionable policies, ensuring her work impacts not only the scientific community but also global health policies. Her efforts amplify the reach of her research, making a lasting impact on public health worldwide. 🌍🩺💉

Leadership

Dr. Dvora Joseph Davey’s leadership in managing large-scale clinical trials and mentoring emerging public health and epidemiology professionals showcases her dedication to education and capacity-building in global public health. As a recipient of the prestigious NIH/Fogarty International Research Scientist Development Award (IRSDA) and the follow-on R01 award, Dr. Davey has solidified her position as a thought leader in the field. Her commitment to fostering continuous learning and improvement within the global health community reflects her deep influence and dedication to advancing public health practices worldwide. 🎓🌍💉👩‍🔬

Ongoing Projects

Dr. Dvora Joseph Davey’s ongoing research, supported by NIH and Gilead Corporation, plays a crucial role in addressing HIV within vulnerable populations. Her work on projects like PrEP-PP and SCOPE-PP, alongside innovative initiatives such as a community-based peer-led intervention to tackle alcohol use and HIV risk in pregnant women, highlights her proactive approach to solving complex public health challenges. Dr. Davey’s research aims to create effective, targeted solutions that address the unique needs of at-risk communities, contributing significantly to advancing HIV prevention and care efforts. 💡🧑‍🔬🩺🌍

Research Focus

Dr. Dvora Joseph Davey is a prominent researcher specializing in HIV prevention, sexually transmitted infections (STIs), and maternal health. Her work focuses on pre-exposure prophylaxis (PrEP) for HIV, examining its safety and efficacy among pregnant and postpartum women. She also explores STI diagnostics, point-of-care testing, and the prevalence of curable STIs in low- and middle-income countries. Her research seeks to improve access to health interventions, particularly for vulnerable populations like men who have sex with men and transgender women. Dr. Davey’s contributions help shape public health strategies for HIV prevention and sexual health. 🦠💉

Publication Top Notes

 

Isabel Cristina Céspedes | Neuropharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Isabel Cristina Céspedes | Neuropharmacology | Best Researcher Award

Assoc Prof Dr Isabel Cristina Céspedes, Escola Paulista de Medicina – UNIFESP, Brazil

Assoc. Prof. Dr. Isabel Cristina Céspedes is a prominent researcher with a focus on genetics, neuroscience, and psychobiology. She obtained her Ph.D. in Morphofunctional Sciences from the University of São Paulo in 2007, specializing in stress-related brain responses in rodents. With postdoctoral work at UNIFESP and extensive teaching experience at universities like USP and UNIP, she explores topics such as substance abuse, epigenetics, and transfusion medicine. She has contributed to numerous publications in journals like Behavioural Brain Research and The Journal of Neuroscience. Her ongoing research investigates the effects of blood transfusions and addiction disorders. 🧠🔬💉📚

Publication Profile

Google Scholar

Educational Background

Assoc. Prof. Dr. Isabel Cristina Céspedes has a distinguished academic background, holding a Ph.D. in Morphofunctional Sciences from the University of São Paulo, specializing in neurobiological responses to stress 🧠. Her postdoctoral research at the Federal University of São Paulo deepened her expertise in genetic and molecular neurobiology 🔬. With a passion for understanding the intricate mechanisms of stress at the molecular level, Dr. Céspedes has contributed significantly to the field, advancing knowledge in neurobiology and stress-related disorders. Her work continues to inspire and shape research in neuroscience and molecular biology 🧬✨.

Leadership in Academia

Dr. Céspedes is an active educator, researcher, and mentor at prestigious institutions such as UNIFESP and USP, where she has made significant contributions to the academic community 📚. With her dedication to higher education, she holds several administrative and leadership roles, guiding academic programs and playing a pivotal part in various committees 🏫💼. Her work reflects a passion for both academic excellence and student mentorship, and her leadership has helped shape the educational landscape at these esteemed institutions 🌟. Through her efforts, Dr. Céspedes continues to inspire and shape future scholars and professionals 🌱.

Research Projects

Dr. Céspedes is conducting pioneering research on the epigenetic effects of blood transfusions, aiming to enhance clinical practices and improve patient outcomes. By examining how transfusions influence gene expression, their work is providing valuable insights into patient health and long-term recovery. Dr. Céspedes’ research contributes to a deeper understanding of the molecular mechanisms involved, which could lead to more personalized medical treatments and better management of transfusion-related complications. This groundbreaking work is opening new avenues in both clinical and genetic research, offering potential advancements in healthcare. 🧬🩸🔬👩‍🔬

Research Focus

Dr. Isabel Cristina Céspedes focuses on neuroscience, particularly in the areas of neuroplasticity, anxiety, stress responses, and neurogenesis. Her research investigates how environmental factors, such as chronic stress and psychological interventions, affect the brain’s defensive responses, Fos immunoreactivity, and hippocampal neurogenesis. She has also explored the effects of substances like alcohol on brain function, including how they alter locomotion and neurocircuitry associated with reward and anxiety. Additionally, Dr. Céspedes contributes to studies on hormonal regulation, particularly cortisol, and its implications for mental health. Her work spans animal models, psychological interventions, and neurobiological mechanisms. 🧠🔬💉📚

Publication Top Notes

Chronic unpredictable mild stress alters an anxiety-related defensive response, Fos immunoreactivity and hippocampal adult neurogenesis

Physical therapy and psychological intervention normalize cortisol levels and improve vitality in women with endometriosis

Una alternativa natural para el tratamiento de la COVID-19

Effects of chronic treatment with corticosterone and imipramine on fos immunoreactivity and adult hippocampal neurogenesis

Environmental enrichment decreases avoidance responses in the elevated T-maze and delta FosB immunoreactivity in anxiety-related brain regions

The Edinger–Westphal nucleus II: Hypothalamic afferents in the rat

Acute restraint differently alters defensive responses and fos immunoreactivity in the rat brain

mRNA expression of corticotropin-releasing factor and urocortin 1 after restraint and foot shock together with alprazolam administration

Alcohol consumption increases locomotion in an open field and induces Fos-immunoreactivity in reward and approach/withdrawal-related neurocircuitries

 

 

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Dr Michael Swedberg, Swedberg Preclinical Partner, Sweden

Dr. Michael Swedberg is a distinguished pharmacologist with extensive expertise in safety pharmacology, CNS pharmacology, gastrointestinal pharmacology, and drug abuse assessment. He has held key leadership roles, including Associate Director at AstraZeneca and founder of Swedberg Preclinical Partner AB. His global impact includes contributions to regulatory compliance, developing novel animal models, and mentoring future researchers. With a Ph.D. in discrimination learning and postdoctoral training at NIDA, Dr. Swedberg has collaborated internationally and received numerous accolades for his innovative research and leadership. His career embodies excellence in pharmacology and preclinical drug discovery. 🌍💊🔬

Publication Profile

scopus

Education

Dr. Michael Swedberg is a distinguished academic and researcher, having earned his Ph.D. in 1985 from the University of Uppsala, Sweden. His doctoral dissertation focused on “A Model of Discrimination Learning with Interoceptive Stimuli.” He completed his postdoctoral fellowship at the National Institutes of Health (NIH), specializing in addiction research at the National Institute on Drug Abuse’s Preclinical Pharmacology Branch in Baltimore, Maryland (1985–1988). Additionally, Dr. Swedberg holds a Bachelor of Social Science (B.S.Sc.) from Uppsala University, with a comprehensive background in psychology, sociology, and law. 🧠📚🎓

Professional Appointments

Dr. Michael Swedberg has had an extensive and distinguished career in pharmacology and drug discovery. From 2014 to 2021, he was the Founder and CEO of Swedberg Preclinical Partner AB in Sweden. Prior to that, he was a Partner and Consultant at The Research Network (TRN) from 2014 to 2016. His earlier career includes key roles at AstraZeneca R&D, where he served as Associate Director in Safety Pharmacology and Preclinical Development. He also held senior leadership positions at Novo Nordisk and Ferrosan. Dr. Swedberg’s journey began as a Lecturer at Mälardalen University in 1981. 🧑‍🔬💉📚

Academic Service

Dr. Michael Swedberg has made significant contributions to the field of pharmacology and neuroscience through various roles. He served as a board member for the Department of Psychology at the University of Uppsala and the Faculty of Social Sciences from 1980 to 1985. His leadership extended to chairing the Council of Graduate Students. Recognized for his service, Dr. Swedberg received awards from the Drug Abuse Liability Ad Hoc Committee and for his work with the Lilly–Novo Nordisk Muscarinic Research Collaboration. He has also been a grant evaluator for the European Union and Poland’s National Centre for Research and Development. 🌍🔬🧠

Presentations

Dr. Michael Swedberg has made significant contributions to the field of drug safety and abuse liability assessment. His research, presented at multiple prestigious meetings, includes the role of drug discrimination studies in evaluating novel compounds’ abuse potential. Notably, his work at the Safety Pharmacology Society, American College of Toxicology, and the Swedish Pharmaceutical Congress has advanced methodologies like rat self-administration and drug discrimination for psychoactive effects. His work on the interaction between mGluR5 antagonists and benzodiazepines also stands out. Swedberg’s contributions to safety pharmacology have had a lasting impact on CNS drug development and regulatory guidelines. 🧠💊

Lecturing and teaching

Dr. Michael Swedberg has delivered extensive lectures and seminars on safety pharmacology, drug abuse, and CNS risk assessment. His contributions include lectures at the American College of Toxicology, Safety Pharmacology Society, and the European Congress of Toxicologic Pathology, focusing on drug dependence, abuse liability, and CNS safety. Additionally, Swedberg has provided in-depth training on the regulatory and industrial challenges in drug development at AstraZeneca and other global platforms. His teaching spans from the biomedical program at Karolinska Institute to the University of Uppsala, covering neuropharmacology, psychopharmacology, and drug addiction. His educational materials are widely respected in the field. 🧠📚💊

Academic Supervision

Dr. Michael Swedberg has mentored numerous students at various stages of their academic careers, including graduate, Ph.D., and postdoctoral researchers. He supervised students at Umeå University, University of Uppsala, and Karolinska Institute, guiding experimental work in fields such as cannabinoid tolerance, dopamine release, and nicotine’s effects on learning. His postdoctoral supervision included projects on visual and auditory discrimination in drug testing. Swedberg’s research has been supported by multiple prestigious grants, such as the Clas Groschinsky Memorial Foundation and the Swedish Medical Research Council. His contributions have significantly advanced brain and behavior research. 🎓🧠💡

Committee Service

Dr. Michael Swedberg held several key roles at AstraZeneca, including membership in the Safety Knowledge Group for CNS and leadership in CNS GLP Safety Pharmacology Harmonization. He was also a part of multiple committees, such as the AstraZeneca Expert Advisory Group on Abuse Liability and the Cross Company Abuse Liability Consortium. Dr. Swedberg contributed to international organizations like PhRMA and CPDD, focusing on drug abuse liability. He attended professional courses in safety pharmacology, project management, and leadership, further enhancing his expertise. Additionally, he completed a teaching course at Karolinska Institute, strengthening his academic influence. 🧠💊🎓

Research Focus

Dr. Michael Swedberg’s research focuses on the pharmacology of muscarinic receptors and their potential therapeutic applications, particularly in relation to neurological and psychiatric disorders. His work has delved into muscarinic receptor agonists, with significant contributions to the understanding of their antipsychotic and antinociceptive properties. Additionally, he has explored the role of nicotinic compounds and their reinforcing effects. His research has implications for treating conditions like schizophrenia, Alzheimer’s disease, and irritable bowel syndrome. 🧠🔬💊 His studies on receptor-ligand interactions and pharmacological profiles contribute to the development of novel drugs for various neurological and gastrointestinal conditions.

Publication Top Notes

Approaches for early identification of abuse potential liability

Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse

Drug Discrimination: Use in Preclinical Assessment of Abuse Liability

AZD9272 and AZD2066: Selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects

Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions

Establishment of auditory discrimination and detection of tinnitus induced by salicylic acid and intense tone exposure in the rat

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Luisa De Cola | Drug Delivery Systems | Best Researcher Award

Prof Luisa De Cola, University of Milan and Mario Negri Institute, Italy

Prof. Luisa De Cola is an accomplished chemist known for her interdisciplinary research in supramolecular and materials chemistry, with applications in biomedical fields. She holds a Laurea in Chemistry from the University of Messina and has held prestigious positions at institutions like the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at Istituto Mario Negri, Milan. With over 400 published papers and 42 patents, she has received numerous awards, including the 2020 Gold Medal “Giulio Natta” and 2014 Chevalier de la Légion d’Honneur. 🏅🔬💡

Publication Profile

Google Scholar

Education

Prof. Luisa De Cola, a renowned scientist, earned her Laurea in Chemistry from the University of Messina in 1983. She has held various prestigious academic roles, including Post-doctoral Fellow at Virginia Commonwealth University, and visiting scientist positions at UCLA, Harvard, and MIT. From 1986 to 1990, she worked as a researcher at the National Research Council in Bologna. She later served as a Full Professor at the University of Amsterdam, University of Münster, and University of Strasbourg. Currently, she is a Full Professor at the University of Milan and Director of the “Materials for Health” unit at the Mario Negri Institute. 🧪🔬🌍

Experience

Prof. Luisa De Cola is a renowned academic and researcher currently serving as a Full Professor at the University of Milan, Italy, since 2020. She is also the Director of the “Materials for Health” unit at Istituto di Ricerche Farmacologiche Mario Negri in Milan. Her distinguished career includes previous roles at prestigious institutions such as the University of Amsterdam, University of Münster, and University of Strasbourg. Prof. De Cola has held notable positions, including chairing molecular photonic materials and nanoelectronics. Her research contributions span nanoelectronics, nanophotonics, and biomaterials. 🌍📚🔬👩‍🔬

Research achievements

Prof. Luisa De Cola’s research is known for its multidisciplinary approach, driven by curiosity and fundamental exploration, often with practical applications. Her work spans supramolecular and material chemistry, focusing on functional luminescent and electro-luminescent assemblies, optical and electroluminescent devices, and dynamic (breakable) materials for biomedical applications. With over 400 published papers in peer-reviewed journals (H-index = 88, over 27,000 citations on Scopus), her research has been featured in prestigious journals like Nature and Nature Chemistry. Her contributions continue to shape innovations in materials science and biomedicine. 🌟🧪🔬📚💡💉

Peer recognition

Prof. Luisa De Cola is a distinguished chemist, awarded numerous prestigious prizes throughout her career. Her accolades include the 1993 Chemistry Prize from the Accademia di Scienze Fisiche e Matematiche di Napoli, the 1995 Federchimica National Prize, and the 2009 European Research Council Advanced Grant Award (Magic). In 2011, she received the IUPAC Prize for distinguished women in chemistry, followed by the 2014 Chevalier de la Légion d’Honneur. Other honors include the 2019 Izatt–Christensen Award, 2020 Giulio Natta Gold Medal, and the 2024 Centenary Prize for Chemistry and Communication. She is also an Honorary Professor at Tianjin University and a Doctor Honoris Causa from Universidad Internacional Menéndez Pelayo. 🏆🔬🎖️🌟

Research Focus

Prof. Luisa De Cola’s research focuses on advanced materials, particularly in the development of luminescent and electrochemical systems for various applications. Her work involves the synthesis and characterization of ruthenium and osmium complexes, often in multi-component systems, exploring their electrochemical behavior, absorption spectra, and photoinduced processes. She investigates biomimetic self-assembly for imaging applications, the creation of highly luminescent lanthanide complexes, and photoinduced energy and electron transfer in dinuclear complexes. Her studies have applications in photonic devices, electroluminescence, and molecular imaging. Her work intersects chemistry, material science, and biological applications. 🔬💡🔋✨

Publication Top Notes

Ruthenium (II) and osmium (II) bis (terpyridine) complexes in covalently-linked multicomponent systems: synthesis, electrochemical behavior, absorption spectra, and …

Controlling and imaging biomimetic self-assembly

White‐light emission from an assembly comprising luminescent iridium and europium complexes

Highly luminescent, triple-and quadruple-stranded, dinuclear Eu, Nd, and Sm (III) lanthanide complexes based on bis-diketonate ligands

When self-assembly meets biology: luminescent platinum complexes for imaging applications

Photoinduced energy and electron transfer processes in rigidly bridged dinuclear Ru/Os complexes

Electroluminescent device with reversible switching between red and green emission

 

Jose M. Soriano | Precision Medicine | Best Researcher Award

Published on by Top Pharmaceutical

Jose M. Soriano | Precision Medicine | Best Researcher Award

Prof Jose M. Soriano, University of Valencia, Spain

Prof. José M. Soriano is a Full Professor at the Faculty of Pharmacy, Universitat de València, specializing in food safety, toxicology, and nutrition. He holds a Ph.D. in Food Safety and Toxicology (2001) and degrees in Pharmacy (1996) and Human Nutrition and Dietetics (2018). He has led over 50 national and international projects and published 199 journal articles. With an impressive citation index of 5,263, Prof. Soriano is also Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics and has published 50 books. His research focuses on nutraceutics, food safety, and toxicology. 📚🍏🔬

Publication Profile

Google Scholar

Academic Background

Prof. José M. Soriano holds a doctorate in Food Safety and Toxicology, along with degrees in Pharmacy and Human Nutrition. With extensive experience in pharmacy, food science, and nutrition research, he is a Full Professor at Universitat de València. His expertise covers critical areas such as food safety, toxicology, and nutrition, where he contributes to advancing scientific understanding. Prof. Soriano’s work bridges academia and practical application, ensuring a deep impact on public health and safety. 🍏🔬📚

Research and Innovations

Prof. José M. Soriano is a distinguished researcher with extensive expertise in food safety, nutrition, and toxicology. He has led over 50 national and international projects, significantly advancing scientific understanding in these critical areas. With more than 5,200 citations and 199 publications in renowned journals, his work has made a lasting impact. Prof. Soriano’s involvement in over 20 consultancy and industry projects further highlights the practical application of his research. His contributions continue to shape the fields of food safety and toxicology, ensuring better public health and informed industry practices. 📚🔬🌍🥗🧬

Editorial and Collaborative Roles

Prof. José M. Soriano is a renowned expert in human nutrition and dietetics, currently serving as the Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics. Through his leadership and extensive collaborations with prestigious institutions across Africa and Asia, he actively contributes to advancing research and education in the field. Prof. Soriano’s dedication to improving global health, particularly through nutrition, has earned him recognition across continents. His work plays a significant role in fostering knowledge exchange and implementing impactful solutions in diverse healthcare settings. 🌍🍏📚💡👨‍⚕️

Professional Recognition

Prof. José M. Soriano is highly esteemed within the scientific community, evident through his memberships in prestigious organizations like the Spanish Academy of Nutrition and Dietetics and the Academy of Pharmacy of the Valencian Community. His recognition in these influential bodies reflects his significant contributions to the fields of nutrition, dietetics, and pharmacy. Through his work, Prof. Soriano has earned respect and credibility, underscoring his dedication to advancing knowledge and practices in these vital areas. His ongoing involvement with these academies is a testament to his ongoing impact and influence. 👨‍⚕️📚🏅

Research Focus

Based on the provided research publications, the individual appears to focus primarily on food safety and toxicology, with a particular interest in mycotoxins and their effects on human health. Their work spans areas like the toxicity, occurrence, and detoxification of mycotoxins such as aflatoxins, zearalenone, and fumonisins. Additionally, they have explored the mechanisms of action of sphingolipids in toxicity, food contamination, and microbiological quality in food products like lettuce and milk. This researcher is also involved in studies on obesity and nutrition, highlighting their expertise in both food toxicology and clinical nutrition. 🧪🍽️🔬🦠

Publication Top Notes

Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin

Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1

Presence of aflatoxin M1 in pasteurized milk from Morocco

Determination of aflatoxins in peanuts by matrix solid-phase dispersion and liquid chromatography

Assessment of the microbiological quality and wash treatments of lettuce served in University restaurants

Incidence of ochratoxin A in rice and dried fruits from Rabat and Salé area, Morocco

Incidence of microbial flora in lettuce, meat and Spanish potato omelette from restaurants